Clinical Trial Update: The Norwegian Immunotherapy in Multiple Myeloma Study

View source ↗

Summary

The Norwegian immunotherapy in multiple myeloma study (NCT06855121) is currently recruiting. It targets multiple myeloma, plasma cell leukemia, and AL amyloidos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Multiple Myeloma
• Plasma Cell Leukemia

Snippet

Sponsor: St. Olavs Hospital | Conditions: Myeloma Multiple, Plasma Cell Leukemia | Status: RECRUITING